Chemical Enterprise Production Management System Based on ERP

October 6, 2017

This paper studies the status and problems of applying ERP systems in chemical enterprises in order to effectively implement the ERP system, reduce production cost, improve economic efficiency and promote scientific and standard management of enterprises. The theory of ERP is described first. Then the problems of production management, the relations between the production department and other departments and so on are analyzed. To solve the above problem, this paper studies the application of ERP in the production management system of the chemical industry to promote successful implementation of ERP system.

Spotlight

Akebia Therapeutics

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. Akebia’s global Phase 3 program for vadadustat, which includes the PRO2TECT studies for non-dialysis patients with anemia associated with chronic kidney disease and the INNO2VATE studies for dialysis-dependent patients, is currently ongoing.

OTHER WHITEPAPERS
news image

Carbon Capture, Transport, & Storage

whitePaper | February 24, 2022

The report “America’s Strategy to Secure the Supply Chain for a Robust Clean Energy Transition” lays out the challenges and opportunities faced by the United States in the energy supply chain as well as the federal government plans to address these challenges and opportunities.

Read More
news image

Boost Your Business In Chemical Industry With Sap Commerce Cloud

whitePaper | April 21, 2023

A B2B E-Commerce platform also provides companies with access to real-time data and insights that can help to inform and guide their business decisions.

Read More
news image

Empowering Operators and Frontline Process Engineers with AI-Powered Operational Analytics

whitePaper | April 12, 2021

Today’s industries face mounting challenges in assuring the best operational performance of assets, both mechanical and process. Managing asset performance is the key element of controlling the operational risk that varying situations can present.

Read More
news image

Modelling of Environmental Ageing of Polymers and Polymer Composites Modular and Multiscale Methods

whitePaper | January 5, 2022

Service lifetimes of polymers and polymer composites are impacted by environmental ageing.

Read More
news image

Trends policy responses and the role of internationalco-operation and trade

whitePaper | January 16, 2022

This paper is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and the arguments employed herein do not necessarily reflect the official views of OECD member countries.

Read More
news image

Understanding Polymer and Hybrid Capacitors

whitePaper | March 24, 2023

Capacitor may seem simple enough but specifying then has allyactu grown more complex in recent years.

Read More

Spotlight

Akebia Therapeutics

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. Akebia’s global Phase 3 program for vadadustat, which includes the PRO2TECT studies for non-dialysis patients with anemia associated with chronic kidney disease and the INNO2VATE studies for dialysis-dependent patients, is currently ongoing.

Events